Notable Insider Buys Filed On July 3

There are many different strategies to trade and one of them is to look for insider purchases of stocks. Any insider trading from corporate officers, key employees, vice presidents, directors, senior management or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. Legal insider trading cannot be based on material non-public information; however, most investors believe that corporate insiders may have better insights into the growth of a company and its proceedings.

In this article, I will focus on notable insider share purchases filed at the Securities and Exchange Commission on July 03, 2012. I have also included the key financial positions of each company and insider trading summaries for three-month and 12-month periods. Use this list as a potential starting point for your analysis.

1. MannKind Corporation (MNKD):MannKind Corporation, a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. MannKind has a market cap of $431.30 million and is currently trading around $2.57 with a 52-week range of $1.57 to $3.99. According to SEC filing on July 03, 2012, MannKind had two insiders combine purchased a total of 31,251,054 shares at a total value of $77,189,555. Multiple insider purchases are usually a positive sign. Over the past 3 months, there have been a total of 7 insider transactions and all of them are Buy transactions. Key financial metric for MannKind is given below:

http://seekingalpha.com/article/701171-notable-insider-buys-filed-on-july-3